Journal or Publishing Institution: Journal of the American Veterinary Medical Association
Study: https://avmajournals.avma.org/doi/abs/10.2460/javma.2000.216.1719
Author(s): Kronfeld, D.S.
Article Type: Journal Publication
Record ID: 1300
Text: In November 1998, an expert panel appointed by the Canadian VMA (CVMA) at the request of Health Canada, but working independently, found “a number of legitimate animal welfare concerns associated with the use of rBST” (recombinant bovine somatotropin). These included an increased risk of clinical mastitis and lameness, and a reduction in the lifespan of treated cows. The panel presented meta-analyses with brief discussion about epidemiologic factors. It concluded that “current health practices… were inadequate to eliminate the increased risk of clinical mastitis and lameness.” This report delayed approval of an rBST drug intended to increase the production of marketable milk…
Keywords: recombinant bovine growth hormone, rBGH, recombinant bovine somatotropin, rBST
Citation: Kronfeld, D.S., 2000. Recombinant bovine somatotropin and animal welfare. Journal of the American Veterinary Medical Association, 216(11), pp.1719-1722.
